Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin:

Haridarshan Patel, PharmD, PhD; Gregory S. Calip, PharmD, MPH, PhD; Robert J. DiDomenico, PharmD; Glen T. Schumock, PharmD, MBA, PhD; Katie J. Suda, PharmD, MS; Todd A. Lee, PharmD, PhD

15 September, 2020

NZ Respiratory Research Review Issue 184

Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis:

Katarina Zeder, MD Alexander Avian, PhD Gerhard Bachmaier, PhD Philipp Douschan, MD Vasile Foris, MD Teresa Sassmann, MD Florentine C. Moazedi-Fuerst, PD Winfried B. Graninger, UP Franz Hafner, PD Marianne Brodmann, UP Wolfgang Salmhofer, UP Horst Olschewski, UP Gabor Kovacs, PD

12 September, 2020

NZ Respiratory Research Review Issue 195

Effect of Normobaric Hypoxia on Exercise Performance in Pulmonary Hypertension - Randomized Trial:

Simon R. Schneider, MA Laura C. Mayer, MD Mona Lichtblau, MD Charlotte Berlier, MD Esther I. Schwarz, MD Stéphanie Saxer, MSc Michael Furian, PhD Konrad E. Bloch, Prof. MD Silvia Ulrich, Prof. MD

8 September, 2020

NZ Respiratory Research Review Issue 195

Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI:

Jonathan Cooke, Carl Llor, Rogier Hopstaken, Matthew Dryden, Christopher Butler

6 September, 2020

NZ Respiratory Research Review Issue 196

Fully weekly antituberculosis regimen: a proof-of-concept study:

Fatma Kort, Laure Fournier Le Ray, Aurélie Chauffour, Vincent Jarlier, Nacer Lounis, Koen Andries, Alexandra Aubry, Lorenzo Guglielmetti, Nicolas Veziris

3 September, 2020

NZ Respiratory Research Review Issue 187

Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study:

Marios Rossides, Susanna Kullberg, Anders Eklund, Daniela Di Giuseppe, Johan Grunewald, Johan Askling, Elizabeth V. Arkema

3 September, 2020

NZ Respiratory Research Review Issue 189

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension:

Raymond L. Benza, MD Manreet K. Kanwar, MD Amresh Raina, MD Jacqueline V. Scott, MS Carol L. Zhao, MS Mona Selej, MD C. Greg Elliott, MD Harrison W. Farber, MD

31 August, 2020

NZ Respiratory Research Review Issue 183

Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension:

Roberto Badagliacca, Michele D’Alto, Stefano Ghio, Paola Argiento, Vincenzo Bellomo, Natale Daniele Brunetti, Gavino Casu, Marco Confalonieri, Marco Corda, Michele Correale, Carlo D’Agostino, Lucrezia De Michele, Giuseppe Galgano, Alessandra Greco, Carlo Lombardi, Giovanna Manzi, Valentina Mercurio, Massimiliano Mulè, Giuseppe Paciocco, Silvia Papa, Emanuele Romeo, Laura Scelsi, Davide Stolfo, Patrizio Vitulo, Robert Naeije, and Carmine Dario Vizza

28 August, 2020

NZ Respiratory Research Review Issue 190

United States Pulmonary Hypertension Scientific Registry - Baseline Characteristics:

Jessica B. Badlam, MD David B. Badesch, MD Eric D. Austin, MD Raymond L. Benza, MD Wendy K. Chung, MD, PhD Harrison W. Farber, MD Kathy Feldkircher, PhD Adaani E. Frost, MD Abby D. Poms, RRT CCRP Katie A. Lutz, BS Michael W. Pauciulo, MBA Chang Yu, PhD William C. Nichols, PhD C. Gregory Elliott, MD on behalf of USPHSR Investigators

25 August, 2020

NZ Respiratory Research Review Issue 195

What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?:

Rebecca J Calthorpe, Sherie J Smith, Nicola J Rowbotham, Paul A Leighton, Gwyneth Davies, Tracey Daniels, Katie Gathercole, Lorna Allen, Zoe C Elliott and Alan R Smyth

16 August, 2020

NZ Respiratory Research Review Issue 203